Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
30,767,343
-
Number of holders
-
43
-
Total 13F shares, excl. options
-
3,305,711
-
Shares change
-
-569,223
-
Total reported value, excl. options
-
$13,020,785
-
Value change
-
-$2,280,443
-
Put/Call ratio
-
6.38%
-
Number of buys
-
19
-
Number of sells
-
-19
-
Price
-
$3.94
Significant Holders of XBiotech Inc. - Common Shares, no par value (XBIT) as of Q4 2017
56 filings reported holding XBIT - XBiotech Inc. - Common Shares, no par value as of Q4 2017.
XBiotech Inc. - Common Shares, no par value (XBIT) has 43 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3,305,711 shares
of 30,767,343 outstanding shares and own 10.74% of the company stock.
Largest 10 shareholders include BlackRock Inc. (916,288 shares), Vanguard Group Inc (810,735 shares), STATE STREET CORP (308,521 shares), NORTHERN TRUST CORP (219,093 shares), GEODE CAPITAL MANAGEMENT, LLC (166,175 shares), SCHWAB CHARLES INVESTMENT MANAGEMENT INC (85,418 shares), GOLDMAN SACHS GROUP INC (77,775 shares), Bank of New York Mellon Corp (57,558 shares), CREDIT SUISSE AG/ (55,061 shares), and TIAA CREF INVESTMENT MANAGEMENT LLC (45,676 shares).
This table shows the top 43 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.